Cambium Bio Limited has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-1234
6ix hasn’t read this filing yet.
Earlier from Cambium Bio
- Cambium 4E and Annual Report
- Notice of General Meeting/Proxy Form
- Response to ASX Aware Query
- Cambium Bio Raises A$3.48 Million in Strategic Placement
- Regeneus Completes the Merger with Cambium
Later from Cambium Bio
- Cambium Bio Successfully Closes A$3.0M Financing Round
- FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol
- Half Year Report (December 2024)Cambium Bio Limited Half Year Report (December 2024) (Feb 27, 2025Feb 27, 2025)
- Cambium Bio Raises A$2.12 million
- Placement Participant Update
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio